Engaging the Private Sector and Developing Partnerships to Advance Health and the Sustainable Development Goals Proceedings of a Workshop—in Brief (2016) / Chapter Skim
Currently Skimming:
Engaging the Private Sector and Developing Partnerships to Advance Health and the Sustainable Development Goals Proceedings of a Workshop-in Brief
Engaging the Private Sector and Developing Partnerships to Advance Health and the Sustainable Development Goals Proceedings of a Workshop-in Brief
Pages 1-7
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 1... ...
member states in September 2015. Boufford acknowledged that the SDGs are the second generation of global goals for development, following the Millennium Development Goals (MDGs)
|
From page 2... ...
David Nabarro, special advisor to the UN Secretary General on the 2030 Agenda for Sustainable Development and Climate Change, echoed Boufford and Gadde's comments on the relevance of health across the goals and the need for collaborative action. During his career as a pediatrician, then a public health professional, and now working on a broad development agenda, Nabarro recognized that to see long-term improvements in the health of populations the underlying causes of morbidity and mortality must be addressed, and addressing them effectively requires work across sectors whether in infectious disease, food and nutrition, noncommunicable diseases, or maternal and child health.
|
From page 3... ...
Susanne Stormer of Novo Nordisk briefly described how Novo Nordisk translates its commitment to sustainable development through the Triple Bottom Line approach. The Triple Bottom Line approach guides the company to be • financially responsible -- focused on long-term business results and balancing financial goals with the economic interests of stakeholders; • socially responsible -- considering the interests of employees, communities, and the people whose medical needs the company serves; and • environmentally responsible -- minimizing the use of natural resources.
|
From page 4... ...
Glenn Rockman from the Global Health Investment Fund described its model for bringing to market promising global health innovations that are in the development pipeline. The fund invests in innovations that can generate investment return while simultaneously making material measurable social impact.
|
From page 5... ...
The priorities for Norway regarding national development are related to challenges associated with consumption patterns and climate change, health issues including noncommunicable diseases and mental health, completion rates in compulsory education, and violence against women. Regarding development assistance, Pedersen suggested that Norway and other highincome countries have a responsibility to help LMICs in their development to advance appropriately and in alignment with the SDGs.
|
From page 6... ...
Voegele emphasized that such a shift does not require changing long-standing policies regarding the allocation of subsidies to specific sectors, but rather a strategic redirection that creates a win–win solution. Raajeev Venkayya from Takeda Pharmaceuticals suggested that the global public health community should look at areas where there have been successful collaborative responses to market failures to extract lessons about the interactions between the private and public sectors, including the regulatory authorities.
|
From page 7... ...
PATH Roger Glass Fogarty International Center SPONSORS: This workshop was supported by Anheuser-Busch InBev; Becton, Richard Guerrant Dickinson and Company; Bill & Melinda Gates Foundation; Catholic Health AssociUniversity of Virginia ation of the United States; e-Development International; Estée Lauder Companies; Trevor Gunn ExxonMobil; Fogarty International Center of the National Institutes of Health; GE; Medtronic Jessica Herzstein Global Health Innovative Technology Fund; Johnson & Johnson; Lockheed Martin U.S. Preventive Services Task Force Corporation; Medtronic; Merck; Novartis Foundation; PATH; PepsiCo; Pfizer Inc.; Ben Hoffman Procter & Gamble; The Rockefeller Foundation; Takeda Pharmaceuticals; United GE Energy Reza Jafari Nations Foundation; University of Notre Dame; UPS Foundation; U.S.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.